Progress in vaccination against Helicobacter pylori

Vaccine

Volumn 19, Issue 17-19, 2001, Pages 2286-2290

  Sutton, Philip ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Helicobacter pylori; Review; Vaccines

Indexed keywords

ADJUVANT; CD4 ANTIGEN; GAMMA INTERFERON; HELICOBACTER PYLORI VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIARRHEA; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MUCOSA; NONHUMAN; PRIORITY JOURNAL; STOMACH MUCOSA; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL VACCINES; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, MUCOSAL; VACCINATION;

EID: 0035925664     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00518-1     Document Type: Conference Paper

References (43)

1. Unidentified curved bacillus on gastric epithelium in active chronic gastritis
2. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
3. Helicobacter pylori and gastric atrophy - Cancer paradoxes
4. Estimates of the worldwide mortality from 25 cancers in 1990
5. Alternative projections of mortality and disability by cause 1990-2020 - Global burden of disease study
6. Antibiotic resistance in Helicobacter pylori infection
7. A small animal model of human Helicobacter pylori active chronic gastritis
8. Immunisation against Helicobacter infection in a mouse/Helicobacter felis model
9. Therapeutic immunisation against Helicobacter infection
10. Development of a mouse model of Helicobacter pylori infection that mimics human disease
11. A standardized mouse model of Helicobacter pylori infection - Introducing the Sydney strain
12. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
13. Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans
14. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets
15. Histochemical study of Helicobacter pylori and surface mucous gel layer in various gastric lesions
16. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses
17. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice
18. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies
19. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions
20. Revisiting the Th1/Th2 paradigm
21. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype
22. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice
23. Helicobacter-specific cell-mediated immune responses display a predominant TH1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice
24. Murine CD4 T-cell response to Helicobacter infection-TH1 cells enhance gastritis and TH2 cells reduce bacterial load
25. Differential stimulation of interleukin-12, (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa
26. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model
27. Replication-defective adenovirus infection reduces Helicobacter felis colonization in the mouse in a gamma interferon- and interleukin-12-dependent manner
28. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
29. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoP(c) expressing urease A and B subunits
30. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B
31. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers
32. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers
33. The complete genome sequence of the gastric pathogen Helicobacter pylori
34. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
35. Comparative genomics of Helicobacter pylori: Analysis of the outer membrane protein families
36. Challenge model for H. pylori infection in human volunteers
37. Further development of the Helicobacter pylori mouse vaccination model
38. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant
39. Protection of BALB/c mice against experimental Helicobacter pylori infection by oral immunisation with H. pylori heparan sulphate-binding proteins coupled to cholera toxin B-subunit
40. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria
41. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice
42. Immunization against natural Helicobacter pylori infection in nonhuman primates
43. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of Rhesus monkeys